[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ admin_label=»Image left, text right» _builder_version=»4.16″ custom_padding=»0|0px|0px|0px|false|false» locked=»off» global_colors_info=»{}»][et_pb_row column_structure=»1_2,1_2″ use_custom_gutter=»on» custom_padding_last_edited=»on|tablet» padding_top_bottom_link_2=»true» padding_left_right_link_2=»false» _builder_version=»4.16″ width=»100%» width_tablet=»80%» width_phone=»80%» width_last_edited=»on|tablet» max_width=»100%» max_width_tablet=»80%» max_width_phone=»80%» max_width_last_edited=»on|tablet» module_alignment=»left» custom_margin=»|auto|-83px|auto|false|» custom_padding=»0|12%|0|0px|false|false» custom_padding_tablet=»|0%||» custom_padding_phone=»» module_alignment_tablet=»center» module_alignment_phone=»center» module_alignment_last_edited=»on|tablet» use_custom_width=»on» width_unit=»off» custom_width_percent=»100%» locked=»off» global_colors_info=»{}»][et_pb_column type=»1_2″ _builder_version=»4.16″ custom_padding=»|||» global_colors_info=»{}» custom_padding__hover=»|||»][et_pb_image src=»https:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/esmonde-yong-9B08uduMyY-unsplash-scaled.jpg» alt=»Nightview of the Petronas Towers in Kuala Lumpur» title_text=»Petronas Tower in Kuala Lumpur» show_bottom_space=»off» force_fullwidth=»on» align_tablet=»center» align_phone=»center» align_last_edited=»on|desktop» _builder_version=»4.16″ background_color_gradient_direction=»90deg» background_color_gradient_start=»#404451″ background_color_gradient_end=»rgba(240,242,246,0)» custom_margin=»|-57px||||» custom_padding=»||||false|false» custom_padding_tablet=»||60px|» custom_padding_phone=»||10px||false|false» custom_padding_last_edited=»on|phone» animation_style=»slide» animation_direction=»left» animation_intensity_slide=»1%» global_colors_info=»{}»][\/et_pb_image][et_pb_text _builder_version=»4.16″ _module_preset=»default» text_font_size=»13px» custom_padding=»|||60px||» global_colors_info=»{}»]<\/p>\n
Featured image: Photo by Esmonde Yong<\/a> on Unsplash<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=»1_2″ _builder_version=»4.16″ custom_padding=»6vw||6vw|» custom_padding_tablet=»0px|0px|0px|0px|false|true» custom_padding_phone=»||||false|false» custom_padding_last_edited=»on|tablet» global_colors_info=»{}» padding_phone=»||||false|false» padding_tablet=»|10%||10%|false|true» padding_last_edited=»on|tablet» custom_padding__hover=»|||»][et_pb_text _builder_version=»4.17.4″ text_font=»||||||||» header_font=»||||||||» header_3_text_color=»#3550a0″ header_6_font=»||||||||» max_width=»930px» min_height=»565.9px» custom_margin=»-81px|-687px|-70px|||» custom_padding=»|0px||0px||» hover_enabled=»0″ header_3_font_size_tablet=»» header_3_font_size_phone=»20px» header_3_font_size_last_edited=»on|desktop» locked=»off» global_colors_info=»{}» sticky_enabled=»0″]<\/p>\n The Malaysian Consumer Healthcare and Prescription Drugs market is growing and has a bright future looming ahead. Continue reading to discover more about this enticing market in South East Asia.\u00a0\u00a0<\/span><\/i><\/p>\n The Malaysian consumer healthcare and pharma indus\u00adtry has shown pro\u00adgres\u00adsive growth over the years, par\u00adtic\u00adu\u00adlarly in the last decade. Recently, eco\u00adnomic indi\u00adca\u00adtions in the coun\u00adtry have begun to look pos\u00adi\u00adtive, which should help sus\u00adtain growth within the OTC and pharma sec\u00adtor.<\/span><\/p>\n According to our forecast, the <\/span>Malaysian OTC and pharma market <\/b>is estimated to be worth around <\/span>USD 3,69 billion in 2035<\/b>, ex-factory, with almost all of the world\u2019s international pharmaceutical companies represented in the country in addition to the local ones.\u00a0<\/span><\/p>\n Cur\u00adrently, the <\/span>local indus\u00adtry meets approx\u00adi\u00admately 30% of domes\u00adtic demand<\/b>, in addi\u00adtion to export\u00ading to other Asia-Pacific coun\u00adtries, the Mid\u00addle East, Africa, Latin Amer\u00adica and Europe. But the rather large remain\u00ading 70% of domes\u00adtic demand is accounted for by imported prod\u00aducts, on which Malaysia is highly depen\u00addent.<\/span><\/p>\n Over the past few years, a number of regulations were implemented by the government to overcome the difficulties the country was experiencing, such as their import reliance weighing on the country\u2019s expenses. Malaysia\u2019s progressive government policy is aimed at attracting international investments, improving the local manufacturing standards, and improving access to other global Islamic markets with new halal production regulations. All of those decisions are <\/span>strengthening the Malaysian OTC and pharma market <\/b>and its future development.\u00a0<\/span><\/p>\n If you are planning on entering Malaysia, our expertise and long-standing network can support you. The Chameleon Pharma Consulting Group has extensive OTC and pharma expertise in South East Asian markets, and we would be thrilled to support you to take advantage of the opportunities this region has to offer!<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=»4.17.4″ _module_preset=»default» min_height=»117px» custom_margin=»54px|auto||auto||» custom_padding=»71px|||||» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_2,1_2″ _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»1_2″ _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»][et_pb_icon font_icon=»||divi||400″ icon_color=»#0B0B7A» _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»][\/et_pb_icon][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n OTC and pharma market size, ex-factory<\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=»1_2″ _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»][et_pb_icon font_icon=»||divi||400″ icon_color=»#0B0B7A» _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»][\/et_pb_icon][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n OTC and pharma market growth<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ admin_label=»Number Counter» _builder_version=»4.16″ _module_preset=»default» background_color=»#EEEEEE» min_height=»404px» custom_margin=»108px|||||» custom_padding=»53px|||||» locked=»off» global_colors_info=»{}»][et_pb_row _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_3,1_3,1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Total population» number=»33 519 406 » percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» number_font_size=»72px» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Male\/Female » number=»1.03″ percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Population growth » number=»1.06%» percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_3,1_3,1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Birth rate » number=»14.72\/1000″ percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» number_font_size=»72px» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Mortality rate » number=»5.66\/1000″ percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Life expectancy» number=»75.87 years» percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»][et_pb_row _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_cta title=»Interested in this market?» button_url=»https:\/\/www.chameleon-pharma.com\/about\/contacts\/» button_text=»Click Here» _builder_version=»4.16″ _module_preset=»default» background_color=»#0B0B7A» global_colors_info=»{}»]<\/p>\n <\/p>\n We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects,\u00a0and more in order to ensure your growth.<\/p>\n [\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" MalaysiaFeatured image: Photo by Esmonde Yong on UnsplashMalaysia: a Consumer Healthcare and Prescription Drugs market full of opportunities The Malaysian Consumer Healthcare and Prescription Drugs market is growing and has a bright future looming ahead. Continue reading to discover more about this enticing market in South East Asia.\u00a0\u00a0 The Malaysian consumer healthcare and pharma indus\u00adtry […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":8782,"menu_order":47,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[caption id=\"attachment_699\" align=\"alignleft\" width=\"427\"]Malaysia: a Consumer Healthcare and Prescription Drugs market full of opportunities<\/b><\/h2>\n
Malaysia OTC and pharma market in 2035<\/h2>\n
USD 3,69 Billion<\/strong><\/h2>\n
5-7%<\/strong><\/h2>\n
Malaysia in numbers<\/h2>\n
![\"\"](\"https:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/2014\/07\/Malaysia-1024x561.jpg\")
when a sun rise from east<\/a> by naim fadil<\/a> with CC<\/a>[\/caption]\r\n\r\nThe Malaysian phar\u00adma\u00adceu\u00adti\u00adcal indus\u00adtry has shown pro\u00adgres\u00adsive growth over the years,<\/strong> par\u00adtic\u00adu\u00adlarly in the last decade. Recently, eco\u00adnomic indi\u00adca\u00adtions in the coun\u00adtry have began to look pos\u00adi\u00adtive, which should help sus\u00adtain growth within the phar\u00adma\u00adceu\u00adti\u00adcal sec\u00adtor.\r\n\r\nThe OTC Health\u00adcare mar\u00adket in Malaysia increased at a com\u00adpound growth rate of 8.3% per year between 2006 and 2012, account\u00ading for 30% of the total mar\u00adket. The remain\u00ading 70% is com\u00adprised of Rx prod\u00aducts.\r\n\r\nMany local man\u00adu\u00adfac\u00adtur\u00aders have recently begun to develop and launch off-patent generic and herbal prod\u00aducts; they are on the look-out for new and inno\u00adv\u00ada\u00adtive prod\u00aducts and licence agree\u00adments from countries out\u00adside Malaysia. Cur\u00adrently, the local indus\u00adtry meets approx\u00adi\u00admately 30% of domes\u00adtic demand<\/strong>, in addi\u00adtion to export\u00ading to other Asia-Pacific coun\u00adtries, the Mid\u00addle East, Africa, Latin Amer\u00adica and Europe. But the rather large remain\u00ading 70% of domes\u00adtic demand is accounted for by imported prod\u00aducts, on which Malaysia is highly depen\u00addent.\r\n\r\nMalaysia has less than 100-150 local phar\u00adma\u00adceu\u00adti\u00adcal man\u00adu\u00adfac\u00adtur\u00aders. How\u00adever, there are many OTC Cos\u00admetic and Med\u00adical Device play\u00aders. The major\u00adity of these man\u00adu\u00adfac\u00adtur\u00aders pro\u00adduce generic drugs, which have gained popularity in Malaysian hospitals and clinics, particularly since the finan\u00adcial cri\u00adsis of 2008-2010, due to their afford\u00adable prices. Fur\u00adther\u00admore, there is an increas\u00ading demand for spe\u00adcial\u00adist treat\u00adment among mid\u00addle- and upper-class Malaysians due to lifestyle-related dis\u00adeases, such as heart com\u00adpli\u00adca\u00adtions and var\u00adi\u00adous forms of can\u00adcer.\r\n\r\nLead\u00ading Malaysian com\u00adpa\u00adnies are now also mov\u00ading towards the pro\u00adduc\u00adtion of bio\u00adlogical drugs, oncol\u00adogy and high-value generic com\u00adpounds, all in line with the grow\u00ading demands of the region. Although the country has voiced objec\u00adtions to cer\u00adtain ele\u00adments in the Transpa\u00adcific Part\u00adner\u00adship Agree\u00adment, it is mak\u00ading progress in terms of trade rela\u00adtions\u2014the gov\u00adern\u00adment began nego\u00adti\u00ada\u00adtions over the cre\u00adation of a Euro\u00adpean Free Trade Agree\u00adment in Novem\u00adber of 2012, which will make gaining access to the promis\u00ading Malaysian OTC and Pharma mar\u00adket less chal\u00adleng\u00ading.\r\n\r\nThe largest phar\u00admacy chain in Malaysia is Guardian and Wat\u00adsons, <\/em>which trans\u00adformed itself from a small inde\u00adpen\u00addent retail store into a lead\u00ading phar\u00adma\u00adceu\u00adti\u00adcal dis\u00adtrib\u00adu\u00adtor for almost 30 million peo\u00adple across the coun\u00adtry. There are, how\u00adever, also many pri\u00advately owned sin\u00adgle drugstores in Malaysia, which offer a solid assort\u00adment of OTC and Rx products, Cosmetics and so on.\r\n\r\n","_et_gb_content_width":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-8803","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/comments?post=8803"}],"version-history":[{"count":9,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8803\/revisions"}],"predecessor-version":[{"id":17495,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8803\/revisions\/17495"}],"up":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8782"}],"wp:attachment":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/media?parent=8803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}